120
+
700
+
37
+
97
%
13700
+
AutoCruitment finds the right patients for your trial at exactly the right time with advanced qualification services. Second line phone screening by clinical professionals further assesses patients’ eligibility against the study inclusion and exclusion criteria.
Second line phone screeners are conducted by dedicated Patient Engagement Specialists or Registered Nurses, depending on the complexity of the study protocol.
We hire RNs that will screen, educate and engage patients
Our clinical team has expertise in a broad range of therapeutic areas
We hire team members that are caring, intelligent, dedicated and reliable
Clinical staff is available from 8 AM - 1 AM Eastern to support patients when they need it
Patients have access to clinical staff in 12 different languages
Reduce site burden by increasing the percentage of qualified patients passed to the sites through this enhanced screening and qualification service.
HIPAA compliant with web and mobile interfaces to capture results of online screener and to store medical records, Secure access of patient contact information, medical records, online screen results
Ability to send and receive SMS messages and emails to patients
Ability to place outbound calls and receive inbound calls from patients
Ability to place outbound video calls and receive inbound video calls from patients
Registered Nurses with experience in the trial therapeutic area and accredited by the National Council of State Boards of Nursing (NCSBN)
Software that tracks contact with patients and provides interfaces for text, voice and video calling
Tracking software to assign trials, patients, tasks to the patient engagement specialists and registered nurses.
Our Clinical Phone Screening allows for highly qualified and motivated patients to quickly be referred to sites, leading to enhanced patient qualification and speeding time to enrollment.
AutoCruitment’s patient recruitment platform supports Sponsors, CRO Partners and Research Sites by decreasing time, risk and cost to bring new therapies to market.
